MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 2,357,558 | $20,063,000 | 5.86% |
GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $704,000 | 0.78% |
Portolan Capital Management | 444,550 | $3,783,000 | 0.50% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 6,511,561 | $55,413,000 | 0.39% |
Opus Point Partners Management, LLC | 62,009 | $528,000 | 0.29% |
Cannell & Co. | 1,051,178 | $8,946,000 | 0.29% |
Tekla Capital Management LLC | 853,787 | $7,266,000 | 0.26% |
Birchview Capital, LP | 42,300 | $360,000 | 0.23% |
Eagle Ridge Investment Management | 94,875 | $807,000 | 0.21% |
MARINER INVESTMENT GROUP LLC | 95,090 | $809,000 | 0.16% |